Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. UNFI
9. SPY
10. EVMN

Go back to Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
Amgen Inc (NASDAQ: AMGN) Delayed: 393.94 +0.77 (0.20%)
Previous Close $393.17    52 Week High $176.85 
Open $393.07    52 Week Low $133.64 
Day High $395.55    P/E 59.33 
Day Low $389.28    EPS $6.64 
Volume 376,588